Exhibit 5.1

 

DLA Piper LLP (US)
1251 Avenue of the Americas
New York, New York 10020-1104
www.dlapiper.com
T 212.335.4500
F 212.335.4501

September 8, 2021

Arbe Robotics Ltd.

HaHashmonaim St. 107

Tel Aviv-Yafo, Israel

 

  RE: Arbe Robotics Ltd. – Registration Statement on Form F-4

 

Ladies and Gentlemen:

 

We have acted as special New York counsel to Arbe Robotics Ltd., a company organized under the laws of the State of Israel (the “Company”), in connection with the proposed issuance of (i) 9,680,736 ordinary shares of the Company, no par value (the “Shares”); (ii) 10,735,680 warrants to acquire ordinary shares of the Company (the “Warrants”) consisting of (a) the 7,623,600 Warrants to be issued pursuant to the warrant agreement, dated as of September 8, 2020, between Industrial Tech Acquisitions, Inc., a Delaware corporation (“ITAC”), and Continental Stock Transfer & Trust Company (as will be amended and restated prior to the issuance of the Warrants pursuant to the terms of the Business Combination Agreement (as defined below), the “Warrant Agreement”) and (b) the 3,112,080 Warrants sold in a private placement by ITAC to Industrial Tech Partners, LLC; (iii) an option to Maxim Group LLC and/or its designees to purchase up to a total of 203,296 units (each consisting of one ordinary share and one Warrant); and (iv) 10,938,976 ordinary shares of the Company underlying the Warrants (the “Warrant Shares”). The Shares, the Warrants, the Units and the Warrant Shares are included in a registration statement on Form F–4 under the Securities Act of 1933, as amended (the “Act”), initially filed with the Securities and Exchange Commission (the “Commission”) on June 21, 2021 (Registration No. 333–257250) (as amended, the “Registration Statement”) relating to the business combination contemplated by the Business Combination Agreement, dated as of March 18, 2021 (the “Business Combination Agreement”), by and among ITAC, the Company and the other parties thereto. This opinion is being furnished in connection with the requirements of Item 601(b)(5) of Regulation S-K under the Act, and no opinion is expressed herein as to any matter pertaining to the contents of the Registration Statement or the proxy statement/prospectus contained therein, other than as expressly stated herein with respect to the issuance of the Warrants.

 

As such counsel, we have examined such matters of fact and questions of law as we have considered appropriate for purposes of this letter. With your consent, we have relied upon certificates and other assurances of officers of the Company and others as to factual matters without having independently verified such factual matters. We are opining herein as to the internal laws of the State of New York and we express no opinion with respect to the applicability thereto, or the effect thereon, of the laws of any other jurisdiction or as to any matters of municipal law or the laws of any local agencies within any state. Various matters concerning the laws of Israel are addressed in the opinion of Erdinast, Ben Nathan, Toledano & Co., which has been separately provided to you. We express no opinion with respect to those matters herein, and, to the extent such matters are necessary to the conclusions expressed herein, we have, with your consent, assumed that the legal conclusions relating to such matters are correct.

 

Our opinion set forth herein is subject to: (i) the effect of bankruptcy, insolvency, reorganization, preference, fraudulent transfer, moratorium or other similar laws relating to or affecting the rights and remedies of creditors; (ii) the effect of general principles of equity, whether considered in a proceeding in equity or at law (including the possible unavailability of specific performance or injunctive relief), concepts of materiality, reasonableness, good faith and fair dealing, and the discretion of the court before which a proceeding is brought; and (iii) the invalidity under certain circumstances under law or court decisions of provisions providing for the indemnification of or contribution to a party with respect to a liability where such indemnification or contribution is contrary to public policy. In addition, we express no opinion as to: (a) any provision for liquidated damages, default interest, late charges, monetary

 

 

 

 

Arbe Robotics Ltd.

September 8, 2021

Page 2

 

penalties, make-whole premiums or other economic remedies to the extent such provisions are deemed to constitute a penalty; (b) consents to, or restrictions upon, governing law, jurisdiction, venue, arbitration, remedies, or judicial relief; (c) waivers of rights or defenses, (d) any provision requiring the payment of attorneys’ fees, where such payment is contrary to law or public policy; (e) the creation, validity, attachment, perfection, or priority of any lien or security interest; (f) advance waivers of claims, defenses, rights granted by law, or notice, opportunity for hearing, evidentiary requirements, statutes of limitation, trial by jury or at law, or other procedural rights; (g) waivers of broadly or vaguely stated rights; (h) provisions for exclusivity, election or cumulation of rights or remedies; (i) provisions authorizing or validating conclusive or discretionary determinations; (j) grants of setoff rights; (k) proxies, powers and trusts; (l) provisions prohibiting, restricting, or requiring consent to assignment or transfer of any right or property; or (m) the severability, if invalid, of provisions to the foregoing effect.

 

Subject to the foregoing and the other matters set forth herein, it is our opinion that, as of the date hereof, when the Warrants shall have been duly registered on the books of the transfer agent and registrar therefor in the name or on behalf of the applicable Warrant holders, and have been issued by the Company in the manner contemplated by the Business Combination Agreement and the Warrant Agreement, the Warrants will be the valid and legally binding obligations of the Company, enforceable against the Company in accordance with the terms of the Warrant Agreement.

 

With your consent, we have assumed (a) that the Warrants and the Warrant Agreement have been or will be duly authorized, executed and delivered by the parties thereto, (b) that the Warrants constitute or will constitute legally valid and binding obligations of the parties thereto other than the Company, enforceable against each of them in accordance with their respective terms, and (c) that the status of the Warrants as legally valid and binding obligations of the parties will not be affected by any (i) breaches of, or defaults under, agreements or instruments, (ii) violations of statutes, rules, regulations or court or governmental orders or (iii) failures to obtain required consents, approvals or authorizations from, or to make required registrations, declarations or filings with, governmental authorities.

 

This opinion is for your benefit in connection with the Registration Statement and may be relied upon by you and by persons entitled to rely upon it pursuant to the applicable provisions of the Act. We consent to your filing this opinion as an exhibit to the Registration Statement and to the reference to our firm in the proxy statement/prospectus under the heading “Legal Matters.” In giving such consent, we do not thereby admit that we are in the category of persons whose consent is required under Section 7 of the Act or the rules and regulations of the Commission thereunder.

 

  Very truly yours,
   
  /s/ DLA Piper LLP (US)